Stek advises Abacus on its acquisition of Pluripharm

Danish pharmaceutical supplier Abacus Medicine A/S has acquired Dutch pharmaceutical wholesaler Pluripharm Group. The group is one of four leading pharmaceutical wholesalers in the Netherlands with a full line of medicines, medical devices and services. Stek advised on the acquisition including the merger control proceeding before the Dutch Competition Authority.

Please click here for the press release.

This might also interest you

Stek advises shareholders Alliander N.V. on €600m hybrid convertible loan provided to Alliander N.V.

Stek advises Elanders AB and LGI Netherlands B.V. in the acquisition of Eijgenhuijsen Exploitatie B.V. and Eijgenhuijsen Precisievervoer B.V.

Stek advises Cargill on the conclusion of a Corporate Power Purchase Agreement with Vattenfall